These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1241 related articles for article (PubMed ID: 28004121)
21. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation. Pang L; Han S; Jiao Y; Jiang S; He X; Li P Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943 [TBL] [Abstract][Full Text] [Related]
22. Anticancer activity of SAHA, a potent histone deacetylase inhibitor, in NCI-H460 human large-cell lung carcinoma cells in vitro and in vivo. Zhao Y; Yu D; Wu H; Liu H; Zhou H; Gu R; Zhang R; Zhang S; Wu G Int J Oncol; 2014 Feb; 44(2):451-8. PubMed ID: 24297449 [TBL] [Abstract][Full Text] [Related]
23. Bergamottin isolated from Citrus bergamia exerts in vitro and in vivo antitumor activity in lung adenocarcinoma through the induction of apoptosis, cell cycle arrest, mitochondrial membrane potential loss and inhibition of cell migration and invasion. Wu HJ; Wu HB; Zhao YQ; Chen LJ; Zou HZ Oncol Rep; 2016 Jul; 36(1):324-32. PubMed ID: 27222242 [TBL] [Abstract][Full Text] [Related]
24. 5-allyl-7-gen-difluoromethoxychrysin enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells. Xie ZH; Quan MF; Liu F; Cao JG; Zhang JS BMC Cancer; 2011 Jul; 11():322. PubMed ID: 21801359 [TBL] [Abstract][Full Text] [Related]
25. Effects of polyphyllin I on growth inhibition of human non-small lung cancer cells and in xenograft. Kong M; Fan J; Dong A; Cheng H; Xu R Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):827-33. PubMed ID: 20978038 [TBL] [Abstract][Full Text] [Related]
26. Galbanic acid potentiates TRAIL induced apoptosis in resistant non-small cell lung cancer cells via inhibition of MDR1 and activation of caspases and DR5. Kim YH; Shin EA; Jung JH; Park JE; Koo J; Koo JI; Shim BS; Kim SH Eur J Pharmacol; 2019 Mar; 847():91-96. PubMed ID: 30689998 [TBL] [Abstract][Full Text] [Related]
27. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo. Katiyar SK; Meeran SM; Katiyar N; Akhtar S Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128 [TBL] [Abstract][Full Text] [Related]
28. Anticancer effects of α-Bisabolol in human non-small cell lung carcinoma cells are mediated via apoptosis induction, cell cycle arrest, inhibition of cell migration and invasion and upregulation of P13K/AKT signalling pathway. Wu S; Peng L; Sang H; Ping Li Q; Cheng S J BUON; 2018; 23(5):1407-1412. PubMed ID: 30570866 [TBL] [Abstract][Full Text] [Related]
29. [Synergistic effect and its possible mechanisms of lidamycin in combination with TRAIL in NSCLC]. Yang J; Chen SZ Yao Xue Xue Bao; 2010 Oct; 45(10):1247-53. PubMed ID: 21348302 [TBL] [Abstract][Full Text] [Related]
30. The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells. Azijli K; van Roosmalen IA; Smit J; Pillai S; Fukushima M; de Jong S; Peters GJ; Bijnsdorp IV; Kruyt FA Cancer Chemother Pharmacol; 2014 Jun; 73(6):1273-83. PubMed ID: 24744163 [TBL] [Abstract][Full Text] [Related]
31. Synergistic Inhibition of Thalidomide and Icotinib on Human Non-Small Cell Lung Carcinomas Through ERK and AKT Signaling. Sun X; Xu Y; Wang Y; Chen Q; Liu L; Bao Y Med Sci Monit; 2018 May; 24():3193-3203. PubMed ID: 29763936 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of preventive and therapeutic activity of novel non-steroidal anti-inflammatory drug, CG100649, in colon cancer: Increased expression of TNF-related apoptosis-inducing ligand receptors enhance the apoptotic response to combination treatment with TRAIL. Woo JK; Kang JH; Jang YS; Ro S; Cho JM; Kim HM; Lee SJ; Oh SH Oncol Rep; 2015 Apr; 33(4):1947-55. PubMed ID: 25672292 [TBL] [Abstract][Full Text] [Related]
33. Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models. Hai J; Sakashita S; Allo G; Ludkovski O; Ng C; Shepherd FA; Tsao MS J Thorac Oncol; 2015 Aug; 10(8):1172-80. PubMed ID: 26200271 [TBL] [Abstract][Full Text] [Related]
34. Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells. Lee HY; Moon H; Chun KH; Chang YS; Hassan K; Ji L; Lotan R; Khuri FR; Hong WK J Natl Cancer Inst; 2004 Oct; 96(20):1536-48. PubMed ID: 15494604 [TBL] [Abstract][Full Text] [Related]
35. Effect of Embelin on TRAIL receptor 2 mAb-induced apoptosis of TRAIL-resistant A549 non-small cell lung cancer cells. Jiang L; Hao JL; Jin ML; Zhang YG; Wei P Asian Pac J Cancer Prev; 2013; 14(10):6115-20. PubMed ID: 24289635 [TBL] [Abstract][Full Text] [Related]
36. Anticancer activity of methylene blue via inhibition of heat shock protein 70. Sanchala D; Bhatt LK; Pethe P; Shelat R; Kulkarni YA Biomed Pharmacother; 2018 Nov; 107():1037-1045. PubMed ID: 30257315 [TBL] [Abstract][Full Text] [Related]
37. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. Sun SY; Yue P; Hong WK; Lotan R Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424 [TBL] [Abstract][Full Text] [Related]
38. Anticancer effects of ginsenoside Rk3 on non-small cell lung cancer cells: in vitro and in vivo. Duan Z; Deng J; Dong Y; Zhu C; Li W; Fan D Food Funct; 2017 Oct; 8(10):3723-3736. PubMed ID: 28949353 [TBL] [Abstract][Full Text] [Related]
39. N-Acetyl-Glucosamine Sensitizes Non-Small Cell Lung Cancer Cells to TRAIL-Induced Apoptosis by Activating Death Receptor 5. Liang Y; Xu W; Liu S; Chi J; Zhang J; Sui A; Wang L; Liang Z; Li D; Chen Y; Niu H Cell Physiol Biochem; 2018; 45(5):2054-2070. PubMed ID: 29533936 [TBL] [Abstract][Full Text] [Related]
40. Suppression of Non-Small Cell Lung Cancer Growth and Metastasis by a Novel Small Molecular Activator of RECK. Shen J; Wang B; Zhang T; Zhu N; Wang Z; Jin J; He Y; Hu M Cell Physiol Biochem; 2018; 45(5):1807-1817. PubMed ID: 29510387 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]